260 related articles for article (PubMed ID: 32458278)
1. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M; Edén D; Siegbahn A
Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.
Åberg M; Eriksson O; Mokhtari D; Siegbahn A
Thromb Haemost; 2014 Apr; 111(4):748-60. PubMed ID: 24336871
[TBL] [Abstract][Full Text] [Related]
3. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
4. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
5. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
7. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
8. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
9. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
[TBL] [Abstract][Full Text] [Related]
10. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
11. Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.
Banfi C; Brioschi M; Lento S; Pirillo A; Galli S; Cosentino S; Tremoli E; Mussoni L
J Thromb Haemost; 2011 Aug; 9(8):1608-19. PubMed ID: 21605334
[TBL] [Abstract][Full Text] [Related]
12. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
13. TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC.
Siegbahn A; Johnell M; Nordin A; Aberg M; Velling T
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):135-41. PubMed ID: 17991872
[TBL] [Abstract][Full Text] [Related]
14. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae.
Awasthi V; Mandal SK; Papanna V; Rao LV; Pendurthi UR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1447-55. PubMed ID: 17413039
[TBL] [Abstract][Full Text] [Related]
15. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
16. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
17. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
Versteeg HH; Spek CA; Slofstra SH; Diks SH; Richel DJ; Peppelenbosch MP
Circ Res; 2004 Apr; 94(8):1032-40. PubMed ID: 15016732
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Hjortoe GM; Petersen LC; Albrektsen T; Sorensen BB; Norby PL; Mandal SK; Pendurthi UR; Rao LV
Blood; 2004 Apr; 103(8):3029-37. PubMed ID: 15070680
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
20. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
